Mohamed Alsharedi

498 total citations
33 papers, 336 citations indexed

About

Mohamed Alsharedi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Mohamed Alsharedi has authored 33 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 5 papers in Surgery. Recurrent topics in Mohamed Alsharedi's work include Cancer Immunotherapy and Biomarkers (9 papers), Lung Cancer Treatments and Mutations (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Mohamed Alsharedi is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Lung Cancer Treatments and Mutations (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Mohamed Alsharedi collaborates with scholars based in United States, Jordan and United Kingdom. Mohamed Alsharedi's co-authors include Emnet A Wassie, Todd Gress, Noman Khan, Rajesh Sehgal, Jennifer L. Dotson, Maria Tria Tirona, Saad Ullah Malik, Abdeladim Elhamdani, Inderjit Mehmi and Amanda K. Arrington and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and European Journal of Nuclear Medicine and Molecular Imaging.

In The Last Decade

Mohamed Alsharedi

32 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohamed Alsharedi United States 9 199 100 65 65 59 33 336
Qingyu Wang China 10 127 0.6× 76 0.8× 38 0.6× 43 0.7× 47 0.8× 48 264
Walid Shalata Israel 11 224 1.1× 141 1.4× 47 0.7× 30 0.5× 48 0.8× 62 388
Alessandro Parisi Italy 11 208 1.0× 119 1.2× 74 1.1× 26 0.4× 62 1.1× 56 404
Naomi Konishi Japan 9 199 1.0× 108 1.1× 123 1.9× 44 0.7× 55 0.9× 24 364
Jue Li China 12 140 0.7× 165 1.6× 65 1.0× 27 0.4× 89 1.5× 26 413
Pietro Di Marino Italy 10 260 1.3× 107 1.1× 45 0.7× 65 1.0× 118 2.0× 24 423
Changsen Leng China 10 109 0.5× 73 0.7× 137 2.1× 33 0.5× 52 0.9× 20 288
Ole Larsen Denmark 8 146 0.7× 81 0.8× 87 1.3× 33 0.5× 55 0.9× 17 332
Katerina Sfiridaki Greece 11 94 0.5× 146 1.5× 33 0.5× 55 0.8× 107 1.8× 17 376
Ricardo Fernandes Canada 12 402 2.0× 171 1.7× 60 0.9× 75 1.2× 73 1.2× 34 531

Countries citing papers authored by Mohamed Alsharedi

Since Specialization
Citations

This map shows the geographic impact of Mohamed Alsharedi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamed Alsharedi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamed Alsharedi more than expected).

Fields of papers citing papers by Mohamed Alsharedi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohamed Alsharedi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamed Alsharedi. The network helps show where Mohamed Alsharedi may publish in the future.

Co-authorship network of co-authors of Mohamed Alsharedi

This figure shows the co-authorship network connecting the top 25 collaborators of Mohamed Alsharedi. A scholar is included among the top collaborators of Mohamed Alsharedi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohamed Alsharedi. Mohamed Alsharedi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Msherghi, Ahmed, Mohannad Abuajamieh, Hamza Salim, et al.. (2025). Comparative diagnostic performance of [68 Ga]Ga-FAPI PET/CT and [18 F]FDGPET/CT in biliary tract cancers: a systematic review and meta-analysis. European Journal of Nuclear Medicine and Molecular Imaging. 52(11). 4200–4212. 2 indexed citations
2.
Alsharedi, Mohamed, et al.. (2022). Paraneoplastic Evans Syndrome in a Patient With Prostate Cancer With Small Cell Transformation. Cureus. 14(4). e24505–e24505. 3 indexed citations
3.
Khan, Noman, et al.. (2021). Cutaneous Disease as a Rare Presentation of Follicular Lymphoma Progression. Journal of Investigative Medicine High Impact Case Reports. 9. 2738462412–2738462412. 1 indexed citations
4.
Alsharedi, Mohamed, et al.. (2021). Immune Checkpoint Inhibitor-Related Pulmonary Toxicity: A Comprehensive Review, Part II. Southern Medical Journal. 114(9). 614–619. 5 indexed citations
5.
Alsharedi, Mohamed, et al.. (2021). COVID-19 induced immune thrombocytopenic purpura: case report. PubMed. 8. 14–14. 4 indexed citations
6.
Alsharedi, Mohamed, et al.. (2021). Response of advanced cutaneous squamous cell carcinoma to immunotherapy: case report. PubMed. 8. 19–19. 5 indexed citations
7.
8.
9.
Khan, Noman & Mohamed Alsharedi. (2020). Bullous Skin Rash: A Rare Case of Palbociclib-Induced Dermatological Toxicity. Cureus. 12(9). e10229–e10229. 6 indexed citations
10.
Alsharedi, Mohamed, et al.. (2019). Immune Checkpoint Inhibitors in Locally Advanced, Unresectable, and Metastatic Upper Gastrointestinal Malignancies. Journal of Gastrointestinal Cancer. 51(2). 611–619. 10 indexed citations
11.
Alsharedi, Mohamed, et al.. (2019). Long-term direct oral anticoagulation in primary osteonecrosis with elevated plasminogen activation inhibitor. SHILAP Revista de lepidopterología. 7. 2050313X19827747–2050313X19827747. 8 indexed citations
12.
Alsharedi, Mohamed, et al.. (2018). Solitary Lytic Bone Metastasis: A Rare Presentation of Small Lymphocytic Leukemia. SHILAP Revista de lepidopterología. 2018. 1–4. 3 indexed citations
13.
Dotson, Jennifer L., et al.. (2018). Neutropenic enterocolitis in patients with FLT3 mutated acute myeloid leukemia undergoing induction chemotherapy with midostaurin. International Journal of Hematology. 109(3). 351–355. 3 indexed citations
14.
Alsharedi, Mohamed, et al.. (2018). Osimertinib for the treatment of patients with EGFRmutation-positive non-small cell lung cancer. Drugs of today. 54(6). 369–369. 5 indexed citations
15.
Alsharedi, Mohamed, et al.. (2018). Check point inhibitors a new era in renal cell carcinoma treatment. Medical Oncology. 35(6). 85–85. 33 indexed citations
16.
Wassie, Emnet A, et al.. (2017). Checkpoint inhibitors: the new treatment paradigm for urothelial bladder cancer. Medical Oncology. 34(10). 170–170. 37 indexed citations
17.
Alsharedi, Mohamed, et al.. (2017). Immunotherapy in triple-negative breast cancer. Medical Oncology. 35(1). 13–13. 82 indexed citations
18.
19.
Alsharedi, Mohamed, et al.. (2016). Immunotherapy in a rare case of primary pelvic retroperitoneal melanoma. BMJ Case Reports. 2016. bcr2016216450–bcr2016216450. 1 indexed citations
20.
Alsharedi, Mohamed, et al.. (2015). Metastatic Sarcomatoid Carcinoma of the Small Intestine: a Case Report of Rare Tumor with Literature Review. Journal of Gastrointestinal Cancer. 47(4). 478–481. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qingyu Wang Breakdown of academic impact, for papers by Walid Shalata Breakdown of academic impact, for papers by Alessandro Parisi Breakdown of academic impact, for papers by Naomi Konishi Breakdown of academic impact, for papers by Jue Li Breakdown of academic impact, for papers by Pietro Di Marino Breakdown of academic impact, for papers by Changsen Leng Breakdown of academic impact, for papers by Ole Larsen Breakdown of academic impact, for papers by Katerina Sfiridaki Breakdown of academic impact, for papers by Ricardo Fernandes
Rankless by CCL
2026